Transforming growth factor engages tace and erbb3 to activate pi3k/akt in erbb2-overexpressing breast cancer and desensitizes cells to trastuzumab

0

Departments of Cancer Biology, Medicine, Pathology, Breast Cancer Research Program, Vanderbilt-Ingram Comprehensive Cancer Center, Vanderbilt University School of Medicine, Nashville, TN; Expression Analysis, Durham, NC; Centro de Investigación del Cáncer, CSIC-Universidad de Salamanca, Spain

Customer comments

No comments were found for Transforming growth factor engages tace and erbb3 to activate pi3k/akt in erbb2-overexpressing breast cancer and desensitizes cells to trastuzumab. Be the first to comment!